glp 1 gip receptor agonist New strategies for the treatment of obesity and metabolic dysfunctions Understand GLP-1/GIP Dual Agonist Tirzepatide

However comparing GLP-1s to metformin is not straightforward, as individual treatment plans may vary and the choice of medication can depend on various factors

DPP4 inhibitors and risk of infections: a metaanalysis of randomized controlled trials

We estimate that people who are homozygous for the risk alleles at both the GLP1R and GIPR loci have a 14.8-fold increased odds (95% confidence interval [6.2, 35.8]) of tirzepatide-mediated vomiting, compared with those homozygous for the non-risk alleles

Narvaez 3 Donghyun Ko 4 Do Han Kim 5 Kenneth J

And fiber can help combat constipation that a GLP-1 can cause

NEJM Evidence, 2024